196 related articles for article (PubMed ID: 25455257)
1. Neuroinflammation as a possible link between cannabinoids and addiction.
Rodrigues LC; Gobira PH; de Oliveira AC; Pelição R; Teixeira AL; Moreira FA; Campos AC
Acta Neuropsychiatr; 2014 Dec; 26(6):334-46. PubMed ID: 25455257
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid-opioid interactions in drug discrimination and self-administration: effect of maternal, postnatal, adolescent and adult exposure to the drugs.
Spano MS; Fadda P; Fratta W; Fattore L
Curr Drug Targets; 2010 Apr; 11(4):450-61. PubMed ID: 20017729
[TBL] [Abstract][Full Text] [Related]
3. Molecular architecture of the cannabinoid signaling system in the core of the nucleus accumbens.
Mátyás F; Watanabe M; Mackie K; Katona I; Freund TF
Ideggyogy Sz; 2007 Mar; 60(3-4):187-91. PubMed ID: 17451066
[TBL] [Abstract][Full Text] [Related]
4. Opportunities for the development of neuroimmune therapies in addiction.
Ray LA; Roche DJ; Heinzerling K; Shoptaw S
Int Rev Neurobiol; 2014; 118():381-401. PubMed ID: 25175870
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid tolerance and dependence: a review of studies in laboratory animals.
González S; Cebeira M; Fernández-Ruiz J
Pharmacol Biochem Behav; 2005 Jun; 81(2):300-18. PubMed ID: 15919107
[TBL] [Abstract][Full Text] [Related]
6. Interactions of neuroimmune signaling and glutamate plasticity in addiction.
Gipson CD; Rawls S; Scofield MD; Siemsen BM; Bondy EO; Maher EE
J Neuroinflammation; 2021 Feb; 18(1):56. PubMed ID: 33612110
[TBL] [Abstract][Full Text] [Related]
7. The neurobiology and evolution of cannabinoid signalling.
Elphick MR; Egertová M
Philos Trans R Soc Lond B Biol Sci; 2001 Mar; 356(1407):381-408. PubMed ID: 11316486
[TBL] [Abstract][Full Text] [Related]
8. Immune system: a possible nexus between cannabinoids and psychosis.
Suárez-Pinilla P; López-Gil J; Crespo-Facorro B
Brain Behav Immun; 2014 Aug; 40():269-82. PubMed ID: 24509089
[TBL] [Abstract][Full Text] [Related]
9. The endogenous opioid system: a common substrate in drug addiction.
Trigo JM; Martin-García E; Berrendero F; Robledo P; Maldonado R
Drug Alcohol Depend; 2010 May; 108(3):183-94. PubMed ID: 19945803
[TBL] [Abstract][Full Text] [Related]
10. Nicotine and cannabinoids: parallels, contrasts and interactions.
Viveros MP; Marco EM; File SE
Neurosci Biobehav Rev; 2006; 30(8):1161-81. PubMed ID: 17049986
[TBL] [Abstract][Full Text] [Related]
11. Influence of the anabolic-androgenic steroid nandrolone on cannabinoid dependence.
Célérier E; Ahdepil T; Wikander H; Berrendero F; Nyberg F; Maldonado R
Neuropharmacology; 2006 Jun; 50(7):788-806. PubMed ID: 16443242
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor signaling and stages of addiction.
Crews FT; Walter TJ; Coleman LG; Vetreno RP
Psychopharmacology (Berl); 2017 May; 234(9-10):1483-1498. PubMed ID: 28210782
[TBL] [Abstract][Full Text] [Related]
13. Induction of innate immune genes in brain create the neurobiology of addiction.
Crews FT; Zou J; Qin L
Brain Behav Immun; 2011 Jun; 25 Suppl 1(Suppl 1):S4-S12. PubMed ID: 21402143
[TBL] [Abstract][Full Text] [Related]
14. Corticostriatal microRNAs in addiction.
Heyer MP; Kenny PJ
Brain Res; 2015 Dec; 1628(Pt A):2-16. PubMed ID: 26253823
[TBL] [Abstract][Full Text] [Related]
15. Endocannabinoid system and opioid addiction: behavioural aspects.
Fattore L; Deiana S; Spano SM; Cossu G; Fadda P; Scherma M; Fratta W
Pharmacol Biochem Behav; 2005 Jun; 81(2):343-59. PubMed ID: 15935459
[TBL] [Abstract][Full Text] [Related]
16. [Synthetic cannabinoids: A new addiction matrix].
Scocard A; Benyamina A; Coscas S; Karila L
Presse Med; 2017 Jan; 46(1):11-22. PubMed ID: 28063756
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoids and ceramide: two lipids acting hand-by-hand.
Velasco G; Galve-Roperh I; Sánchez C; Blázquez C; Haro A; Guzmán M
Life Sci; 2005 Aug; 77(14):1723-31. PubMed ID: 15958274
[TBL] [Abstract][Full Text] [Related]
18. [Addictions].
Karila L; Benyamina A
Rev Mal Respir; 2019 Feb; 36(2):233-240. PubMed ID: 30686556
[TBL] [Abstract][Full Text] [Related]
19. Neurochemical basis of cannabis addiction.
Maldonado R; Berrendero F; Ozaita A; Robledo P
Neuroscience; 2011 May; 181():1-17. PubMed ID: 21334423
[TBL] [Abstract][Full Text] [Related]
20. Targeting neuroinflammation: The therapeutic potential of ω-3 PUFAs in substance abuse.
Peng S; Peng Z; Qin M; Huang L; Zhao B; Wei L; Ning J; Tuo QH; Yuan TF; Shi Z; Liao DF
Nutrition; 2021 Mar; 83():111058. PubMed ID: 33360033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
